Neil Jonathan Closner serves as Independent Director of the Company. Mr. Closner has over two decades of start-up, technology and health care experience. Mr. Closner currently serves as Chief Executive Officer and a director of LAVVAN Inc., a company that manufactures pure cannabinoid isolates through a yeast-based cellular agriculture platform. Immediately prior, from February 2013 to July 2018, he was the founder, Chief Executive Officer and a director of Canada-based MedReleaf Corp. Mr. Closner served as Vice President of Business Development at Toronto’s Mount Sinai Hospital, where he launched and managed a number of entrepreneurial enterprises within the hospital. Mr. Closner began his career as a health care-focused investment banker with Salomon Smith Barney (now Citigroup) and has also served as the founder, Chief Executive Officer and/or director of more than half a dozen technology and health care-related start-up companies. He served two terms as the Chairman of the Board of the Cannabis Canada Council, the national industry association that represents the majority of Canada’s licensed cannabis producers. Mr. Closner studied economics at the London School of Economics and Political Science and received his Bachelor of Arts degree from McGill University and a Master of Business Administration degree from the Wharton School at the University of Pennsylvania. He brings to the board extensive leadership experience in the medical cannabis industry as well as experience in mergers and acquisitions.
Neil Closner is 46, he's been the Independent Director of Greenlane Inc since 2019. There are 4 older and 8 younger executives at Greenlane Inc. The oldest executive at Greenlane Holdings Inc is Richard Taney, 64, who is the Independent Director.
Neil's mailing address filed with the SEC is C/O GREENLANE HOLDINGS, INC., 1095 BROKEN SOUND PARKWAY, SUITE 300, BOCA RATON, FL, 33487.
Over the last 6 years, insiders at Greenlane Inc have traded over $53,841,969 worth of Greenlane Inc stock and bought 363,575 units worth $1,298,604 . The most active insiders traders include Vida Investments, Llc Kamen..., Adam Schoenfeld y Aaron Lo Cascio. On average, Greenlane Inc executives and independent directors trade stock every 20 days with the average trade being worth of $398,336. The most recent stock trade was executed by Craig A. Snyder on 22 May 2023, trading 1,200 units of GNLN stock currently worth $384.
greenlane is the leading distributor of premium brands in the burgeoning head shop, smoke shop, and dispensary channels. since 2005, greenlane has worked diligently to build a reputation as the industry leader by meeting the needs of our customers, suppliers, and the end-users of the products we distribute. we have achieved this by offering the most innovative products at competitive prices, providing white glove customer service, and processing orders quickly with unparalleled, highly efficient operations and logistics. during this time, we have grown to over 100 employees with operations in 5 cities across the united states and canada, and we continue to grow by finding ways to better serve the needs of our customers and suppliers.
Greenlane Inc executives and other stock owners filed with the SEC include: